The Race Between Biotech And Techbio [Forbes]
Exscientia Plc - American Depositary Shares (EXAI)
Company Research
Source: Forbes
Nvidia joined forces with Recursion, one of the few AI biotech companies that have assets in Phase 2 or Phase 3 trials, to accelerate foundational models in biology and chemistry at an unprecedented scale in the biopharma space. This collaboration, along with others, exemplifies the growing "techbio" industry, which leverages technology to expedite drug discovery. As Kimberly Powell, head of Nvidia's healthcare segment, aptly shared in a Bloomberg report , data can "drive what biology they're going after, instead of the biology influencing what technology they need to use," emphasizing the synergy between the two fields. However, it's important to acknowledge the long history of collaboration between AI and biotech. Since the birth of bioinformatics in the 1960s, scientists have been harnessing computational approaches like analyzing protein sequences to make advancements in drug discovery. The present iteration of techbio builds upon this rich foundation, taking the collaboration
Show less
Read more
Impact Snapshot
Event Time:
EXAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAI alerts
High impacting Exscientia Plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
EXAI
News
- EXSCIENTIA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Exscientia plc. and Encourages Investors to Contact the FirmGlobeNewswire
- DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Exscientia plc with Losses to Contact the FirmAccesswire
- DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ExscientiaGlobeNewswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Exscientia p.l.c. of Class Action Lawsuit and Upcoming Deadlines - EXAIPR Newswire
- EXSCIENTIA PLC (NASDAQ: EXAI) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Exscientia plcGlobeNewswire
EXAI
Earnings
- 3/21/24 - Beat
EXAI
Sec Filings
- 4/24/24 - Form 144
- 4/22/24 - Form 6-K
- 4/8/24 - Form 144
- EXAI's page on the SEC website